Literature DB >> 31744836

CX3CR1-fractalkine axis drives kinetic changes of monocytes in fibrotic interstitial lung diseases.

Flavia R Greiffo1, Valeria Viteri-Alvarez1, Marion Frankenberger1, Daniela Dietel1, Almudena Ortega-Gomez2, Joyce S Lee3, Anne Hilgendorff1,4,5,6, Jürgen Behr7,8, Oliver Soehnlein2,9,10, Oliver Eickelberg1,3,11, Isis E Fernandez12,6,11.   

Abstract

Circulating immune cell populations have been shown to contribute to interstitial lung disease (ILD). In this study, we analysed circulating and lung resident monocyte populations, and assessed their phenotype and recruitment from the blood to the lung in ILD. Flow cytometry analysis of blood samples for quantifying circulating monocytes was performed in 105 subjects: 83 with ILD (n=36, n=28 and n=19 for nonspecific interstitial pneumonia, hypersensitivity pneumonitis and connective-tissue disease-associated ILD, respectively), as well as 22 controls. Monocyte localisation and abundance were assessed using immunofluorescence and flow cytometry of lung tissue. Monocyte populations were cultured either alone or with endothelial cells to assess fractalkine-dependent transmigration pattern. We show that circulating classical monocytes (CM) were increased in ILD compared with controls, while nonclassical monocytes (NCM) were decreased. CM abundance correlated inversely with lung function, while NCM abundance correlated positively. Both CCL2 and CX3CL1 concentrations were increased in plasma and lungs of ILD patients. Fractalkine co-localised with ciliated bronchial epithelial cells, thereby creating a chemoattractant gradient towards the lung. Fractalkine enhanced endothelial transmigration of NCM in ILD samples only. Immunofluorescence, as well as flow cytometry, showed an increased presence of NCM in fibrotic niches in ILD lungs. Moreover, NCM in the ILD lungs expressed increased CX3CR1, M2-like and phagocytic markers. Taken together, our data support that in ILD, fractalkine drives the migration of CX3CR1+ NCM to the lungs, thereby perpetuating the local fibrotic process.
Copyright ©ERS 2020.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31744836     DOI: 10.1183/13993003.00460-2019

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  8 in total

Review 1.  Biology of lung macrophages in health and disease.

Authors:  Helena Aegerter; Bart N Lambrecht; Claudia V Jakubzick
Journal:  Immunity       Date:  2022-09-13       Impact factor: 43.474

2.  CRTH2 Mediates Profibrotic Macrophage Differentiation and Promotes Lung Fibrosis.

Authors:  Yueming Cao; Jahnavi Rudrakshala; River Williams; Shade Rodriguez; Parand Sorkhdini; Alina X Yang; Miles Mundy; Dongqin Yang; Amy Palmisciano; Thomas Walsh; Cesar Delcompare; Tanis Caine; Luca Tomasi; Barry S Shea; Yang Zhou
Journal:  Am J Respir Cell Mol Biol       Date:  2022-08       Impact factor: 7.748

3.  Optimised generation of iPSC-derived macrophages and dendritic cells that are functionally and transcriptionally similar to their primary counterparts.

Authors:  Susan Monkley; Jayendra Kumar Krishnaswamy; Melker Göransson; Maryam Clausen; Johan Meuller; Kristofer Thörn; Ryan Hicks; Stephen Delaney; Louise Stjernborg
Journal:  PLoS One       Date:  2020-12-17       Impact factor: 3.240

4.  Increased monocyte count and red cell distribution width as prognostic biomarkers in patients with Idiopathic Pulmonary Fibrosis.

Authors:  Demosthenes Bouros; Michael Kreuter; Argyrios Tzouvelekis; Theodoros Karampitsakos; Sebastiano Torrisi; Katerina Antoniou; Effrosyni Manali; Ioanna Korbila; Ourania Papaioannou; Fotios Sampsonas; Matthaios Katsaras; Eirini Vasarmidi; Despoina Papakosta; Kalliopi Domvri; Eva Fouka; Ioannis Organtzis; Zoe Daniil; Ilias Dimeas; Paraskevi Kirgou; Konstantinos I Gourgoulianis; Ilias C Papanikolaou; Katerina Markopoulou; Georgia Kounti; Eirini Tsapakidou; Efthymia Papadopoulou; Konstantinos Tatsis; Athena Gogali; Konstantinos Kostikas; Vasilios Tzilas; Serafeim Chrysikos; Spyridon Papiris
Journal:  Respir Res       Date:  2021-05-05

5.  S100A9/CD163 expression profiles in classical monocytes as biomarkers to discriminate idiopathic pulmonary fibrosis from idiopathic nonspecific interstitial pneumonia.

Authors:  Masahiro Yamashita; Yuh Utsumi; Hiromi Nagashima; Hiroo Nitanai; Kohei Yamauchi
Journal:  Sci Rep       Date:  2021-06-09       Impact factor: 4.379

Review 6.  Regulation and function of CX3CR1 and its ligand CX3CL1 in kidney disease.

Authors:  Sibylle von Vietinghoff; Christian Kurts
Journal:  Cell Tissue Res       Date:  2021-05-19       Impact factor: 4.051

Review 7.  Pathogenesis of Anti-melanoma Differentiation-Associated Gene 5 Antibody-Positive Dermatomyositis: A Concise Review With an Emphasis on Type I Interferon System.

Authors:  Huifang Hu; Hang Yang; Yi Liu; Bing Yan
Journal:  Front Med (Lausanne)       Date:  2022-01-24

8.  Low Circulating Monocytes Is in Parallel With Lymphopenia Which Predicts Poor Outcome in Anti-melanoma Differentiation-Associated Gene 5 Antibody-Positive Dermatomyositis-Associated Interstitial Lung Disease.

Authors:  Xia Lv; Yuyang Jin; Danting Zhang; Yixuan Li; Yakai Fu; Suli Wang; Yan Ye; Wanlong Wu; Shuang Ye; Bing Yan; Xiaoxiang Chen
Journal:  Front Med (Lausanne)       Date:  2022-01-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.